Polymyxin heteroresistance in Klebsiella oxytoca

  01 April 2026

This study highlights that heteroresistance—where a small subpopulation of bacteria is much more resistant than the majority—occurs in Klebsiella oxytoca, a pathogen linked to hospital infections. All tested isolates showed significant resistance differences (8–16-fold) between the main bacterial population and resistant subgroups, which were stable and unaffected by growth conditions or human serum. The resistance was linked to specific changes in the bacterial outer membrane (lipid A modification). These findings suggest that such hidden resistance can be missed by standard diagnostics and may contribute to treatment failure, complicating the effective use of last-resort antibiotics like polymyxins.

Author(s): Eunice A. Ayerakwa et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!